Substack · BioEquity Watch
Nuvation Bio ($NUVB) : The bane of rare cancers?
Rating: BULLISH | Target Price: $10.91 | Current Price: $6.10 | Implied Change: +78.85%
Since publication BLSH −28.0% α −28.4 pp vs S&P 500 · USD
US · 7 entries · 2 publications
BLSH
Bullish
- Entries
- 7
- Bullish
- 2
- Bearish
- 0
- First
- Jul 8, 2025
- Latest
- Sep 18, 2026
More bullish than bearish among those that state a stance.
Jan 25 – Oct 26 · per month
Full performance tracking Pro · free during launch
Alpha of every thesis on BLSH at 1, 3 and 6 months and since publication, and the full chart vs its benchmark.Free during launch: log in or sign up with your email to see it.
Sign up freeTimeline
Newest to oldest- September 2026 1 entry
- July 2026 1 entry
Substack · BioEquity Watch
Outpatient Disruptor or Micro-Cap Gamble? : The Asymmetric Case for Immix Biopharma ($IMMX)
Rating: BULLISH | Target Price: $21.20 | Current Price: $8.95 | Implied Change: +155.68%
Since publication BLSH +15.2% α +11.6 pp vs S&P 500 · USD
- May 2026 2 entries
Substack · BioEquity Watch
Mannkind Corp - Will today's PDUFA be a boom or a bust?
Rating: BULLISH | Target Price: $8.50 | Current Price: $3.64 | Implied Upside: +134%
Since publication −20.9% α −22.2 pp vs S&P 500 · USD
Substack · BioEquity Watch
DD: BioCryst Pharmaceuticals
Rating: BULLISH | Target Price: $22.00 | Current Price: $9.20 | Implied Upside: +139%
Since publication BLSH −36.8% α −40.5 pp vs S&P 500 · USD
- October 2025 1 entry
Blogs · ValueWalk
Why Investors are Bullish on EU’s Most Valuable Firm Despite Mixed Earnings
Dutch semiconductor company ASML recently became the most valuable firm in the EU as measured by its market cap.
Since publication BLSH −52.0% α −67.9 pp vs S&P 500 · USD
- August 2025 1 entry
Blogs · ValueWalk
1 Big Reason Why Wall Street Analysts are Bullish on TJX Stock
TJX Companies has been getting a lot of attention from Wall Street analysts recently, as it has received several price target upgrades.
Since publication BLSH −56.9% α −75.3 pp vs S&P 500 · USD
- July 2025 1 entry
Blogs · ValueWalk
Wall Street Analysts are Bullish on These 2 Casino Gambling Stocks
Wall Street analysts at Goldman Sachs recently initiated coverage of gambling stocks, and they are particularly bullish on two casino gambling stocks
Since publication BLSH −59.4% α −78.1 pp vs S&P 500 · USD
Prices as of the Oct 27, 2026 close. Past performance does not guarantee future results. Price-only, excluding dividends, in local currency. Data may be delayed or inaccurate. Not investment advice. How it is calculated.